FDA Adverse Event Malfunction Summary report: N

TRIAGE CARDIAC PANEL

MDR report key: 1172689 · Received September 20, 2008

Report

Report Number
2027969-2008-00013
Event Type
Malfunction
Date Received
September 20, 2008
Date of Event
July 31, 2008
Report Date
September 19, 2008
Manufacturer
BIOSITE INCORPORATED
Product Code
MMI
PMA / PMN Number
K030286
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

RETAINS TESTED WITH RETURNED PT SPECIMENS. PRODUCT SUPPORT (PS) OBSERVED HIGH TNI AND CK-MB RESULTS ON TRIAGE AND LOW RESULTS ON ACCESS. PS ALSO OBSERVED THAT THE ADDITION OF HAMA INTERFERENCE BLOCKERS LOWERED TNI AND CK-MB SIGNAL 7-FOLD AND 3-FOLD. USING A SEMI-QUANTITATIVE HAMA ACTIVITY ELISA, PS OBSERVED FOR ONE SERUM SAMPLE THAT THE AMOUNT OF HUMAN ANTI-MOUSE IGG WAS CLOSE TO OR ABOVE THE HIGH END OF THE RANGE FOR NORMAL HEALTHY MALES (BASED ON PRODUCT INSERT). LOT REVIEW INDICATED NO FAILURE. RISK ASSESSMENT AND CAPA EVAL PENDING.

Description of Event or Problem · 1

PT HAD POSITIVE CKMB AND TROPONIN I (TNI) RESULTS. WAS TREATED FOR MI WITH HEPARIN INFUSION BEFORE LAB RESULTS RETURNED WITH NORMAL LEVELS. CATHETERIZATION WAS ORDERED BUT CANCELLED DUE TO RESULTS FROM THE LAB. SAMPLE TESTED 2008, 4:58P RESULTS WERE CKMB-29.1, MYO=138, TNI=0.72. REDRAW AT 5:41PM WAS CKMB=23.1, MYO=149, TNI=0.37. 2ND REDRAW AT 6:48PM WAS CKMB=20.1, MYO=113, TNI=0.38. LAB RESULTS ON HEPARIN SAMPLE (UNK DRAW TIME) - CKMB= 3.2, TNI=<0.01. UNK METHOD. PT WAS ADMITTED FOR MONITORING POSSIBLE MI BUT HAS NOT REPORTED ANY ADVERSE EFFECTS DUE TO HEPARIN TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TRIAGE CARDIAC PANEL CARDIAC MARKER TEST MMI BIOSITE INCORPORATED 97000HS W43180

Patients

Seq Age Sex Outcome Treatment
1